# International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

> **NCT06566183** · PHASE3 · NOT_YET_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 1200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Cognitive Impairment
- Heart Failure

## Interventions

- **PROCEDURE:** Guideline-directed medical therapy (GDMT)
- **PROCEDURE:** Coronary artery bypass grafting (CABG)
- **PROCEDURE:** Percutaneous coronary intervention (PCI).

## Key facts

- **NCT ID:** NCT06566183
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2030-12
- **Final completion:** 2032-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566183, "International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06566183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*